The present invention relates to a method of preparing a therapeutic peptidecomposition comprising a carrier peptide and a PKC activity modulating cargopeptide,whereby the resulting therapeutic peptide composition has increased stabilityand potencyrelative to an unmodified therapeutic peptide.